Figure 1From: Tomotherapy concomitant with cetuximab, followed by cetuximab as single-agent therapy for unresectable squamous cell carcinoma of the skin: a case report On left the lesion at baseline (March 2012) and on right the lesion at follow up (October 2013). Back to article page